Search

Your search keyword '"Otorhinolaryngologic Diseases microbiology"' showing total 205 results

Search Constraints

Start Over You searched for: Descriptor "Otorhinolaryngologic Diseases microbiology" Remove constraint Descriptor: "Otorhinolaryngologic Diseases microbiology"
205 results on '"Otorhinolaryngologic Diseases microbiology"'

Search Results

1. ENT manifestations of tuberculosis: an important aspect of ENT practice.

2. Coagulase-negative staphylococci (CoNS) as a significant etiological factor of laryngological infections: a review.

3. [The role of the microbiome in otorhinolaryngology].

4. Staphylococcus aureus from ocular and otolaryngology infections are frequently resistant to clinically important antibiotics and are associated with lineages of community and hospital origins.

5. Intracranial suppurative complications of ear, nose and throat infections: A single-centre cohort study of 65 patients.

6. [The peculiar features of epidemiology and clinical course of syphilis encountered in the otorhinolaryngological practice under the present-day conditions].

7. [The peculiar features of the microbial paysage and the problems of antibacterial therapy of the inflammatory ENT diseases in the patients presenting with diabetes mellitus].

8. Antimicrobial treatment of ENT infections.

9. [Infectious ENT emergencies].

10. ENT mucormycosis. Report of 4 cases.

11. [The post-streptococcal diseases in the clinical practice].

12. Nationwide surveillance of 6 otorhinolaryngological infectious diseases and antimicrobial susceptibility pattern in the isolated pathogens in Japan.

13. Deep Neck Infection: A Review of 130 Cases in Southern China.

14. Update on disorders and treatment of the guttural pouch.

15. [Persistent infections in the children presenting with chronic ENT diseases: the potential of etiotropic therapy].

16. Presentation, diagnosis and management of neck abscesses in children.

17. In defence of 'dye therapy'.

18. The role of the human microbiome in otolaryngology-head and neck surgery: a contemporary review.

19. Determination of the biofilm formation capacity of bacterial pathogens associated with otorhinolaryngologic diseases in the Malaysian population.

21. [Antibiotherapy of severe ENT infections in children: propositions of the French Group of Pediatric Infectious Diseases (PID) of the French Society of Pediatrics].

22. [Primary mucosal tuberculosis of head and neck region: a clinicopathologic analysis of 47 cases].

23. Descriptive analysis of healthcare-associated infections other than bloodstream, respiratory, urinary tract, or surgical site infections, 2001-2011.

25. [Intracranial complications from ENT infections].

26. Tuberculosis presenting as bilateral vocal fold palsy: case report and review of otolaryngological manifestations of tuberculosis.

27. [Head and neck tuberculosis - still current problem in ENT practice].

28. Chapter 2-5-2. Anaerobic infections (individual fields): anaerobic infections of the head and neck.

29. Chapter 2-11. Anaerobic infections (individual fields): otorhinolaryngological infections.

30. Diagnosis of tuberculosis in the head and neck.

31. Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment.

32. Otolaryngologic community-acquired MRSA infections in a suburban private practice.

33. Treatment of methicillin-resistant Staphylococcus aureus pediatric head and neck infections: results of a national survey of otolaryngologists in the United States.

34. Tularaemia outbreaks in Sakarya, Turkey: case-control and environmental studies.

35. [Mutant prevention concentrations of garenoxacin against Streptococcus pneumoniae isolates from otorhinolaryngological infections].

36. [Lemierre syndrome associated with vascular purpura in a patient with dilated cardiomyopathy].

37. Lemierre syndrome caused by acute isolated sphenoid sinusitis and its intracranial complications.

38. Microbiology in complicated head and neck infections.

39. Role of methicillin-resistant Staphylococcus aureus in head and neck infections.

40. [Clinical position of sitafloxacin in outpatient chemotherapy. (discussion)].

41. [Antimicrobial susceptibility surveillance of recent isolates from otorhinolaryngological infections to garenoxacin and other antimicrobial drugs].

42. [Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections].

43. [State of the art diagnosis and treatment of ENT mycotic diseases].

44. Nationwide trends in pediatric Staphylococcus aureus head and neck infections.

45. [Fungal infection in the otorinolaryngologic area].

46. Biofilms and their role in otorhinolaryngological disease.

47. Pediatric neck abscesses: changing organisms and empiric therapies.

48. [Pharmacological properties and clinical efficacy of garenoxacin mesilate hydrate (Geninax Tablet 200 mg), a quinolone antimicrobial].

49. Antibacterial activity of mometasone furoate.

50. Acute rise in methicillin-resistant Staphylococcus aureus infections in a coastal community.

Catalog

Books, media, physical & digital resources